Trinity Biotech reported $141.21M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Bayer EUR 33.46B 875M Mar/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
J&J USD 54.9B 2.82B Jun/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
OraSure Technologies USD 25.12M 18.96M Jun/2026
Plus Therapeutics USD 7.96M 4.36M Mar/2026
Roche Holding CHF 28.85B 846M Jun/2026
Siemens EUR 45.11B 4.4B Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Tosoh JPY 391.91B 37.39B Jun/2026
Trinity Biotech USD 141.21M 106.72M Dec/2025
Veracyte USD 62.74M 6.62M Jun/2026